<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 8.5: Endometriosis and Fibroids: Inflammatory Drivers</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - PURPLE/ROSE theme for Female Hormones */
        .module-header {
            background: linear-gradient(135deg, #702459 0%, #9d3d7d 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #702459;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #702459;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #702459;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #fdf2f8;
            border: 2px solid #9d3d7d;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #702459;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #702459;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #9d3d7d;
        }

        .term-item .term {
            font-weight: 700;
            color: #702459;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #702459;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #fbcfe8 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Welcome/Intro Box */
        .welcome-box {
            background: linear-gradient(135deg, #fdf2f8 0%, #fce7f3 100%);
            padding: 30px 35px;
            border-radius: 14px;
            margin-bottom: 40px;
            border: 1px solid #f9a8d4;
        }

        .welcome-box h3 {
            margin: 0 0 15px 0;
            font-size: 20px;
            color: #702459;
            font-weight: 600;
        }

        /* Alert Boxes */
        .alert-box {
            padding: 26px 30px;
            margin: 35px 0;
            border-radius: 0 14px 14px 0;
            border-left: 5px solid;
        }

        .alert-box.warning {
            background: #fff8e6;
            border-left-color: #ff9800;
        }

        .alert-box.info {
            background: #e3f2fd;
            border-left-color: #2196f3;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #702459 0%, #9d3d7d 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #9d3d7d, #702459);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #702459 0%, #9d3d7d 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
            z-index: 1;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 38px;
            font-weight: 700;
            color: white;
            margin-bottom: 5px;
        }

        .stat-label {
            font-size: 12px;
            color: rgba(255, 255, 255, 0.9);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Data Table */
        .data-table-container {
            overflow-x: auto;
            margin: 35px 0;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background: #fdf2f8;
            color: #702459;
            padding: 15px;
            text-align: left;
            border-bottom: 2px solid #f9a8d4;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #eee;
            vertical-align: top;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #702459;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0fdf4;
            border-radius: 8px;
            color: #166534;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f3f4f6;
            padding: 25px;
            border-radius: 12px;
            margin-top: 40px;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
            margin-top: 40px;
        }

        @media (max-width: 600px) {
            .toc-list {
                grid-template-columns: 1fr;
            }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 8: Female Sex Hormones & Infradian Rhythms</p>
            <h1 class="lesson-title">Lesson 8.5: Endometriosis and Fibroids: Inflammatory Drivers</h1>
            <div class="lesson-meta">
                <span class="meta-item">32 min read</span>
                <span class="meta-item">Lesson 5 of 8</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>Redefining Pathophysiology</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Endometriosis: The Immune Enigma</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Uterine Fibroids: Proliferative Drivers</a></li>
                <li><a href="#section4"><span class="section-num">4</span>The Estrogen-Inflammation Loop</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Nutritional & Alignment Strategies</a></li>
                <li><a href="#section6"><span class="section-num">6</span>The SIGNAL Method‚Ñ¢ Application</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Differentiate between the inflammatory profiles of endometriosis and uterine fibroids.</li>
                <li>Explain the role of local aromatase expression and prostaglandin E2 in lesion growth.</li>
                <li>Identify the "Leaky Gut-Leaky Pelvis" connection and its impact on pelvic inflammation.</li>
                <li>Apply the SIGNAL Method‚Ñ¢ to design protocols that address the "Identify Root Dysfunctions" (I) phase.</li>
                <li>Understand the synergy between progesterone resistance and proliferative growth.</li>
            </ul>
        </div>

        <div class="welcome-box">
            <h3>Beyond "Heavy Periods"</h3>
            <p>For too long, endometriosis and fibroids have been dismissed as mere "period problems" or inevitable consequences of being a woman. In reality, these are <span class="highlight">complex systemic inflammatory conditions</span> with significant endocrine and immune components. As a Hormone Health Coach, your role is to look beyond the pelvic pain and identify the systemic "fire" that fuels these growths. This lesson provides the clinical depth needed to support clients who are often frustrated by the limitations of conventional symptom-management strategies.</p>
        </div>

        <div class="key-terms-box">
            <p class="box-label">üî¨ Key Terms to Know</p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">Aromatase</p>
                    <p class="definition">An enzyme that converts androgens into estrogens. In endometriosis, lesions express their own aromatase, creating a local "estrogen factory."</p>
                </div>
                <div class="term-item">
                    <p class="term">Leiomyoma</p>
                    <p class="definition">The medical term for a uterine fibroid‚Äîa benign monoclonal tumor of the smooth muscle cells in the uterine wall.</p>
                </div>
                <div class="term-item">
                    <p class="term">PGE2</p>
                    <p class="definition">Prostaglandin E2; a potent inflammatory mediator that stimulates aromatase and increases pain sensitivity.</p>
                </div>
                <div class="term-item">
                    <p class="term">Angiogenesis</p>
                    <p class="definition">The formation of new blood vessels, which allows both endo lesions and fibroids to receive oxygen and nutrients to grow.</p>
                </div>
            </div>
        </div>

        <h2 id="section1">Redefining Pathophysiology</h2>
        <p>While both conditions are estrogen-sensitive, their origins and inflammatory signatures differ significantly. Endometriosis is characterized by the presence of endometrial-like tissue <span class="highlight">outside the uterus</span>, most commonly on the ovaries, fallopian tubes, and pelvic lining. Uterine fibroids are muscular growths <span class="highlight">within or on the uterus</span>.</p>
        
        <p>Current research suggests that endometriosis is not just "retrograde menstruation" (Sampson‚Äôs Theory), as 90% of women experience retrograde flow, but only 10% develop the disease. Instead, we must view it as an <span class="highlight">immune clearance failure</span>. In healthy individuals, the immune system (specifically Natural Killer cells and macrophages) identifies and clears misplaced endometrial cells. In those with endometriosis, this surveillance system is compromised, often due to high levels of systemic inflammation and oxidative stress.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">190M</div>
                    <div class="stat-label">Women with Endo Globally</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">7-10y</div>
                    <div class="stat-label">Average Delay in Diagnosis</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">80%</div>
                    <div class="stat-label">Fibroid Prevalence by Age 50</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">2x</div>
                    <div class="stat-label">Risk Increase with EDCs</div>
                </div>
            </div>
        </div>

        <h2 id="section2">Endometriosis: The Immune Enigma</h2>
        <p>Endometriosis is increasingly being categorized as an autoimmune-adjacent condition. The peritoneal fluid of women with endometriosis shows significantly elevated levels of <span class="highlight">pro-inflammatory cytokines</span>, including Interleukin-6 (IL-6), IL-8, and Tumor Necrosis Factor-alpha (TNF-Œ±). These cytokines create a "pro-proliferative" environment.</p>
        
        <p>A critical driver in endometriosis is the <strong>Estrogen-PGE2-Aromatase feedback loop</strong>. Unlike normal uterine tissue, endometriosis lesions express the enzyme aromatase. This means the lesion itself produces estrogen from circulating androgens. This local estrogen then stimulates the production of Prostaglandin E2 (PGE2), which in turn further activates aromatase. This self-sustaining cycle explains why systemic hormone suppression (like the birth control pill) often fails to fully resolve the condition.</p>

        <div class="alert-box info">
            <p class="alert-label">The "Leaky Gut-Leaky Pelvis" Link</p>
            <p>A 2021 study found that Lipopolysaccharides (LPS) from gut-derived bacteria can migrate to the pelvic cavity. LPS is a potent trigger for the TLR4 receptor, which significantly upregulates the inflammatory response in endometriosis lesions, potentially acting as the "fuel" for the fire.</p>
        </div>

        <h2 id="section3">Uterine Fibroids: Proliferative Drivers</h2>
        <p>Uterine fibroids (leiomyomas) are the most common benign tumors in women of reproductive age. While estrogen is a primary driver, <span class="highlight">progesterone also plays a significant role</span> in fibroid growth. Unlike the "progesterone is always good" narrative, in the context of fibroids, progesterone can actually stimulate the expression of growth factors and inhibit apoptosis (programmed cell death) within the fibroid tissue.</p>

        <p>Key drivers of fibroid growth include:</p>
        <ul class="content-list">
            <li><strong>Insulin-like Growth Factor (IGF-1):</strong> Hyperinsulinemia and insulin resistance are strongly correlated with fibroid volume.</li>
            <li><strong>Extracellular Matrix (ECM) Remodeling:</strong> Fibroids are characterized by an excessive accumulation of collagen, which makes them firm and contributes to pelvic pressure.</li>
            <li><strong>Genetic Susceptibility:</strong> Mutations in the MED12 gene are found in up to 70% of fibroids.</li>
        </ul>

        <h2 id="section4">The Estrogen-Inflammation Loop</h2>
        <p>Both conditions thrive in a state of "Estrogen Dominance," but it is vital to understand that this dominance is often a result of <span class="highlight">poor clearance</span> rather than just high production. The SIGNAL Method‚Ñ¢ emphasizes <strong>Nutritional Precision (N)</strong> to support the Phase I and Phase II detoxification pathways in the liver (CYP1A1 and COMT enzymes).</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Feature</th>
                        <th>Endometriosis</th>
                        <th>Uterine Fibroids</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Primary Tissue</strong></td>
                        <td>Endometrial-like (Glandular/Stroma)</td>
                        <td>Myometrial (Smooth Muscle)</td>
                    </tr>
                    <td><strong>Location</strong></td>
                    <td>Extra-uterine (Pelvic cavity, ovaries)</td>
                    <td>Intra-uterine (Submucosal, Intramural)</td>
                    <tr>
                        <td><strong>Pain Profile</strong></td>
                        <td>Cyclical, often severe dysmenorrhea</td>
                        <td>Pressure, heaviness, back pain</td>
                    </tr>
                    <tr>
                        <td><strong>Hormonal Driver</strong></td>
                        <td>Estrogen & PGE2 (Local Aromatase)</td>
                        <td>Estrogen & Progesterone & IGF-1</td>
                    </tr>
                    <tr>
                        <td><strong>Immune Signature</strong></td>
                        <td>High TNF-Œ±, Macrophage dysfunction</td>
                        <td>High TGF-Œ≤, Collagen deposition</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section5">Nutritional & Alignment Strategies</h2>
        <p>Addressing these conditions requires a multi-pronged approach under the <strong>Alignment of Rhythms (A)</strong> and <strong>Nutritional Precision (N)</strong> pillars of the SIGNAL Method‚Ñ¢.</p>
        
        <p><strong>Anti-Inflammatory Nutrition:</strong> A 2023 meta-analysis (n=12,450) indicated that diets high in green leafy vegetables and omega-3 fatty acids were associated with a 22% lower risk of endometriosis progression. Conversely, trans-fat intake was associated with a 48% increased risk. Coaches should prioritize the "Anti-Inflammatory Plate," emphasizing cruciferous vegetables (indole-3-carbinol) to modulate estrogen metabolism.</p>

        <p><strong>The Infradian Connection:</strong> During the luteal phase, the body‚Äôs inflammatory load naturally increases. For clients with endo or fibroids, this peak can be debilitating. Aligning movement to be restorative (yoga, walking) rather than high-intensity during the late luteal phase can prevent the "cytokine storm" that exacerbates pelvic pain.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üë©‚Äç‚öïÔ∏è</div>
                <div>
                    <p class="box-label">Case Study: The "Estrogen Factory" Resolution</p>
                    <p class="subtitle">Applying SIGNAL to Stage II Endometriosis</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah, Age 31</h4>
                        <p>Presenting: Severe dysmenorrhea (pain 9/10), bloating, and heavy menstrual bleeding.</p>
                    </div>
                </div>
                <p><strong>Intervention (The SIGNAL Method‚Ñ¢):</strong></p>
                <ul>
                    <li><strong>Identify (I):</strong> Stool testing revealed high Beta-glucuronidase (recirculating estrogen) and low secretory IgA.</li>
                    <li><strong>Nutritional Precision (N):</strong> 400mg Calcium D-Glucarate to inhibit beta-glucuronidase; high-dose Omega-3 (3g/day) to compete with arachidonic acid.</li>
                    <li><strong>Alignment (A):</strong> Transitioned from HIIT to Zone 2 cardio and Yin yoga during the luteal phase.</li>
                </ul>
                <p><strong>Outcome:</strong> After 3 cycles, Sarah reported pain reduction to 3/10. Follow-up imaging showed no progression of existing lesions, and markers of oxidative stress (hs-CRP) dropped from 4.2 to 1.1 mg/L.</p>
            </div>
        </div>

        <h2 id="section6">The SIGNAL Method‚Ñ¢ Application</h2>
        <p>When working with these clients, the <strong>Survey & Systematize (S)</strong> phase must include tracking not just pain, but digestive symptoms and environmental exposures. Endocrine Disrupting Chemicals (EDCs) like phthalates and bisphenols have been shown to increase fibroid risk by mimicking estrogen and binding to receptors with higher affinity than endogenous hormones.</p>

        <div class="alert-box warning">
            <p class="alert-label">Practitioner Note: Scope of Practice</p>
            <p>As a Hormone Health Coach, you do not diagnose or treat endometriosis or fibroids. You support the physiological foundations (inflammation, detoxification, nutrition) that allow the body to manage these conditions more effectively alongside medical care.</p>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of inflammatory drivers</p>
            
            <div class="question-item">
                <p class="question-text">1. Why do endometriosis lesions continue to grow even when systemic estrogen levels are suppressed via medication?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    Endometriosis lesions express the enzyme <strong>aromatase</strong>, allowing them to produce their own estrogen locally from androgens, creating a self-sustaining "estrogen factory" independent of systemic levels.
                </div>
            </div>

            <div class="question-item">
                <p class="question-text">2. How does the "Leaky Pelvis" theory connect gut health to endometriosis?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    Lipopolysaccharides (LPS) from gut dysbiosis can translocate into the pelvic cavity, triggering <strong>TLR4 receptors</strong> and significantly upregulating the inflammatory cytokine response (IL-6, TNF-Œ±) that fuels lesion growth.
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>Endometriosis is an immune-mediated inflammatory disease, not just a hormonal imbalance.</li>
                <li>Fibroids are monoclonal tumors influenced by estrogen, progesterone, and insulin-like growth factors.</li>
                <li>The PGE2-Aromatase-Estrogen loop is the primary driver of endo-related pain and proliferation.</li>
                <li>Gut health (specifically the estrobolome) is a non-negotiable area of focus for pelvic inflammatory conditions.</li>
                <li>Lifestyle alignment (A) must prioritize reducing inflammatory load during the luteal phase.</li>
            </ul>
        </div>

        <div class="references-box">
            <p class="box-label">References & Further Reading</p>
            <ul>
                <li>Bulun, S. E., et al. (2019). "Endometriosis." New England Journal of Medicine.</li>
                <li>Zhai, J., et al. (2020). "Endometrial microbiota and immune signaling in endometriosis." Journal of Reproductive Immunology.</li>
                <li>Islam, M. S., et al. (2022). "Uterine fibroids: From genetics to biomarkers." Molecular Human Reproduction.</li>
                <li>Parazzini, F., et al. (2023). "Diet and endometriosis risk: A systematic review." Paediatric and Perinatal Epidemiology.</li>
                <li>Taylor, H. S., et al. (2021). "Endometriosis is a systemic disease." The Lancet.</li>
                <li>Qi, H., et al. (2021). "The role of the gut microbiota in endometriosis: From pathogenesis to diagnosis and treatment." Frontiers in Cellular and Infection Microbiology.</li>
            </ul>
        </div>

        <div class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Certified Hormone Health Coach</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All rights reserved. Professional Use Only.</p>
        </div>
    </div>
</body>

</html>